ArTS Archivio della ricerca di Trieste

FANIN, RENATO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.178
AS - Asia 2.533
EU - Europa 1.432
SA - Sud America 415
AF - Africa 159
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 9.719
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.099
SG - Singapore 1.121
SE - Svezia 431
CN - Cina 373
HK - Hong Kong 337
BR - Brasile 315
VN - Vietnam 299
IT - Italia 172
FR - Francia 145
RU - Federazione Russa 120
KR - Corea 119
PL - Polonia 113
DE - Germania 96
MA - Marocco 96
BG - Bulgaria 85
IE - Irlanda 83
GB - Regno Unito 64
BD - Bangladesh 62
IN - India 62
CA - Canada 46
AR - Argentina 34
MX - Messico 20
TR - Turchia 20
UA - Ucraina 20
ZA - Sudafrica 20
FI - Finlandia 19
IQ - Iraq 19
ID - Indonesia 18
EC - Ecuador 17
BE - Belgio 16
ES - Italia 15
NL - Olanda 15
JP - Giappone 14
PK - Pakistan 13
CL - Cile 11
CO - Colombia 10
SN - Senegal 10
JO - Giordania 9
AE - Emirati Arabi Uniti 8
AT - Austria 7
CH - Svizzera 7
DZ - Algeria 7
EG - Egitto 7
KE - Kenya 7
NP - Nepal 7
PY - Paraguay 7
BO - Bolivia 6
CZ - Repubblica Ceca 5
ET - Etiopia 5
LT - Lituania 5
PE - Perù 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
VE - Venezuela 5
IL - Israele 4
JM - Giamaica 4
PH - Filippine 4
UY - Uruguay 4
CR - Costa Rica 3
HU - Ungheria 3
MN - Mongolia 3
OM - Oman 3
RO - Romania 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
TW - Taiwan 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
GA - Gabon 2
IR - Iran 2
KG - Kirghizistan 2
KW - Kuwait 2
KZ - Kazakistan 2
LB - Libano 2
LV - Lettonia 2
MY - Malesia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BS - Bahamas 1
BT - Bhutan 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GY - Guiana 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
LA - Repubblica Popolare Democratica del Laos 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PT - Portogallo 1
RS - Serbia 1
YT - Mayotte 1
Totale 9.719
Salva come PNG Salva come JPEG
Città #
Singapore 809
Ashburn 697
Fairfield 615
Hong Kong 334
San Jose 319
Woodbridge 277
Chandler 257
Wilmington 242
Houston 241
Seattle 239
Cambridge 207
Princeton 166
Boardman 153
Beijing 143
Ann Arbor 137
Seoul 115
Ho Chi Minh City 106
Santa Clara 104
Chicago 94
Lauterbourg 89
Casablanca 88
Jacksonville 86
Sofia 84
Dublin 83
Zgierz 81
Columbus 77
Los Angeles 62
The Dalles 59
Hanoi 56
Moscow 51
Milan 50
Dallas 47
San Diego 45
New York 40
Frankfurt am Main 33
São Paulo 33
Hefei 31
Warsaw 28
Düsseldorf 24
Orem 20
Buffalo 17
Da Nang 17
Montreal 17
Brussels 15
Miano 15
Trieste 15
Helsinki 14
Brooklyn 13
Chennai 13
Johannesburg 13
Norwalk 13
London 12
Phoenix 12
Tokyo 12
Memphis 11
Toronto 11
Dakar 10
Munich 10
Rio de Janeiro 10
Washington 10
Bremen 9
Haiphong 9
Poplar 9
Redondo Beach 9
Amman 8
Atlanta 8
Campinas 8
Can Tho 8
Portsmouth 8
Santiago 8
Andover 7
Charlotte 7
Mexico City 7
Monmouth Junction 7
Stockholm 7
Tianjin 7
Baghdad 6
Bern 6
Biên Hòa 6
Boston 6
Curitiba 6
Fremont 6
Lahore 6
Nanjing 6
Pune 6
Raleigh 6
Shanghai 6
Ankara 5
Augusta 5
Belo Horizonte 5
Cairo 5
Council Bluffs 5
Guangzhou 5
Guayaquil 5
Kocaeli 5
Manchester 5
Mumbai 5
Nairobi 5
San Antonio 5
Vienna 5
Totale 6.939
Salva come PNG Salva come JPEG
Nome #
Anti-CD20 therapy for chronic lymphocytic leukemia-associated autoimmune diseases 179
Efficacy and safety of rituximab in type II mixed cryoglobulinemia 178
Impact of hepatitis C virus infection on clinical features, quality of life and survival of patients with lymphoplasmacytoid lymphoma/immunocytoma 178
Incidence, outcome, and risk factors of late-onset noninfectious pulmonary complications after unrelated donor stem cell transplantation 177
Low-dose rituximab in adult patients with primary immune thrombocytopenia 175
Bendamustine in chronic lymphocytic leukemia: Outcome according to different clinical and biological prognostic factors in the everyday clinical practice 173
Efficacy of selective B cell Blockade in the treatment of rheumatoid arthritis: evidence for a pathogenetic role of B cells 163
Bendamustine salvage therapy for T cell neoplasms 162
Acute hepatic failure as onset of progressive sclerodermatous chronic graft-versus-host disease after donor lymphocyte infusion 160
B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia 160
Activity of all-trans-retinoic acid in a case of central nervous system extramedullary relapse of acute promyelocytic leukemia 159
Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia 159
Rituximab in immune thrombocytopenia: gender, age, and response as predictors of long-term response 158
Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long-term follow-up results 158
A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi 158
Rituximab for the treatment of type II mixed cryoglobulinemia 156
CHOP-rituximab with pegylated liposomal doxorubicin for the treatment of elderly patients with diffuse large B-cell lymphoma 156
B-cell compartment as the selective target for the treatment of immune thrombocytopenias 155
The genotype of the hepatitis C virus in patients with HCV-related B cell non-Hodgkin's lymphoma 152
Autologous stem cell transplantation for Hodgkin's lymphoma: results and prognostic factors in 51 high-risk patients 151
Dapsone salvage therapy for adult patients with immune thrombocytopenia relapsed or refractory to steroid and rituximab 150
Prognostic significance of delayed thrombocytopenia after allogeneic stem cell transplant 150
Management of immune thrombocytopenia in elderly patients 148
Long-term follow-up analysis after rituximab salvage therapy in adult patients with immune thrombocytopenia 147
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: correlations with clinicobiologic parameters 143
Alpha-interferon as maintenance drug after initial fludarabine therapy for patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphoma 141
Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia 139
Surgical staging in Hodgkin's disease: the role of laparoscopic splenectomy 138
T-cell chimerism and clinical outcome after reduced-intensity conditioning allogeneic stem cell transplantation 137
A retrospective analysis of 144 patients with aggressive non-Hodgkin's lymphoma: impact of aurtologoaus stem cell transplantation in first remission on autcome 129
Rituximab in a case of cold agglutinin disease 127
Lamivudine allows completion of chemotherapy in lymphoma patients with hepatitis B reactivation 127
CD38, BCL-2, PD-1 and PD-1L expression in nodal peripheral T-cell lymphoma (PTCL): Possible biomarkers for novel targeted therapies? 127
Brentuximab vedotin in combination with extended field radiotherapy as salvage treatment for primary refractory Hodgkin lymphoma 124
Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura 124
Hepatitis C virus infection among cryoglobulinemic and non-cryoglobulinemic B-cell non-Hodgkin’s lymphomas 124
BCL-2 immunohistochemical evaluation in B-cell chronic lymphocytic leukemia and hairy cell leukemia before treatment with fludarabine and 2-chloro-deoxy-adenosine 124
Earlier administration of Rituximab allows higher rate of long-lasting response in adult patients with autoimmune thrombocytopenia 121
Clinical features and outcome of multiple myeloma arising from the transformation of a monoclonal gammapathy of undetermined significance 121
Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopenia 120
High-dose therapy in multiple myeloma: effect of positive selection of CD34+ peripheral blood stem cells on hematologic engraftment and clinical outcome 119
Granulocyte colony-stimulating factor (G-CSF) allows the delivery of effective doses of CHOP and CVP regimens in non-Hodgkin lymphomas 116
Second-line rituximab, lenalidomide, and bendamustine in mantle cell lymphoma: A phase II clinical trial of the fondazione italiana linfomi 116
Treatment of refractory chronic GVHD with rituximab: a GITMO study 111
Intensified full-dose induction therapy (HD-MACHOP+radiotherapy) follwed dy consolidation with BAVC regimen and autologous stem cell transplantation as fron-line therapeutic approach for high risk aggressive non Hodgkin lymphoma 110
Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: Results of a retrospective, observational GIMEMA study 110
Paraneoplastic cerebellar degeneration associated with anti-neuronal anti-Tr antibodies in a patient with Hodgkin's disease 107
New drugs and allogeneic hematopoietic stem cell transplantation for hematological malignancies: do they have a role in bridging, consolidating or conditioning transplantation treatment? 107
Long-lasting complete remission of hepatitis C virus (HCV) infection and HCV-associated immunocytoma with alpha-interferon treatment 106
Predicting lymphoma in Sjögren's syndrome and the pathogenetic role of parotid microenvironment through precise parotid swelling recording 105
Nocardiosis with favourable clinical outcome in progressive B-chronic lymphocytic leukaemia 105
Endogenous endophthalmitis following disseminated fungemia due to Fusarium solani in a patient with acute myeloid leukemia 104
Computed tomography, magnetic resonance and gallium 67 scintigraphy for the imaging of residual lymphoma 104
Prevalence of Hepatitis C Virus infection in patients with lymphoproliferative disorder 104
The role of granulocyte colony-stimulating factor (filgrastim) in maintaining dose intensity during conventional-dose chemotherapy with ABVD in Hodgkin's disease 103
Meningeal and cerebral involvement in multiple myeloma patients 102
Risk of C virus infection in Waldenstrom’s syndromes and monoclonal gammopathies 102
High-dose therapy and autologous stem cell transplantation for high-risk Hodgkin's lymphoma: a single center experience 102
Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana Linfomi 100
The therapy of primary adult systemic CD30-positive anaplastic large cell lymphoma: results of 40 cases treated in a single center 99
Thalidomide before autologous stem cell transplantation in VAD-refractory multiple myeloma patients 96
Sequential intensive treatment with the F-MACHOP regimen (+/- radiotherapy) and autologous stem cell transplantation for primary systemic CD30 (Ki-1)--positive anaplastic large cell lymphoma in adults 94
Fludarabine: an active agent in the treatment of previously-treated and untreated low-grade non-Hodgkin's lymphoma 93
Primary systemic CD30 (Ki-1)-positive anaplastic large cell lymphoma of the adult: sequential intensive treatment with the F-MACHOP regimen (+/- radiotherapy) and autologous bone marrow transplantation 91
Retrospective analysis of 23 cases with peripheral T-cell lymphoma, unspecified: clinical characteristics and outcome 90
The role of Rituximab in the therapy of mixed cryoglobulinemia 89
Hepatitis C virus infection (and additional neoplasms) among marginal zone lymphomas 89
The F-MACHOP regimen in the treatment of aggressive non-Hodgkin’s lymphomas: a single centre experience in 72 patients 89
Hepatitis C virus and lymphoproliferative disorders 86
Pixantrone for the treatment of adult patients with relapsed or refractory aggressive non-Hodgkin B-cell lymphomas 84
Myasthenia gravis after allogeneic bone marrow transplantation: a case report 83
Two cases of concomitant diffuse large B-cell lymphoma and myelodysplastic syndrome 80
No evidence for B-cell clonality by spectratyping analysis in patients with idiopathic thrombocytopenic purpura undergoing rituximab therapy” 80
Sclerodermatous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: incidence, predictors and outcome 80
Neutralizing anti-interferon-alpha antibodies and response to treatment in patients with Ph+ chronic myeloid leukaemia sequentially treated with recombinant (alpha 2a) and lymphoblastoid interferon-alpha 79
Prognostic factors and outcome of Epstein-Barr virus DNAemia in high-risk recipients of allogeneic stem cell transplantation treated with preemptive rituximab 77
Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies 77
Effect on survival of the development of late-onset non-infectious pulmonary complications after stem cell transplantation 73
The development of autoantibodies after allogeneic stem cell transplantation is related with chronic graft-vs-host disease and immune recovery 72
Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: clinical results and effects on microenvironment and neo-angiogenic biomarkers 71
Retrospective analysis of 34 cases of hairy cell leukemia treated with interferon-alpha and/or 2-chlorodeoxyadenosine 70
Fludarabine + prednisone +/- alpha-interferon followed or not by alpha-interferon maintenance therapy for previously untreated patients with chronic lymphocytic leukemia: long term results of a randomized study 67
Myasthenia gravis after allogeneic bone marrow transplantation. A case report and a review of the literature 53
Occurrence of multiple myeloma after fludarabine treatment of a chronic lymphocytic leukemia: evidence of a biclonal derivation and clinical response to autologous transplantation 52
Early chemosensitivity to VAD regimen predicts a favorable outcome after autologous stem cell transplantation in multiple myeloma 50
High JAK2V617F allele burden in low-risk PV: an additional recommendation to start “early” cytoreduction? Results from a multicentric study 7
Totale 10.032
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.547
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.547
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021181 0 0 0 0 0 0 0 0 0 0 0 181
2021/2022937 17 106 2 131 4 23 49 32 113 73 38 349
2022/2023971 117 127 102 60 101 191 1 104 114 17 32 5
2023/2024689 28 29 69 15 33 94 122 181 30 10 44 34
2024/20251.629 3 242 273 98 111 134 76 70 112 154 140 216
2025/20263.573 373 122 191 444 319 276 558 110 361 585 135 99
Totale 10.032